This inventor holds 5 USPTO granted patents and 7 published patent applications, plus 4 CIPO patents and 2 EPO patents. Top assignees: Pharma Mar, S.a., Sociedad Unipersonal, Modra Pharmaceuticals B.v., Pharma Mar, S.a.. Active years: 2013-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Amsterdam, NL (2013 - 2019)
- HN Amsterdam, NL (2023)
Company Filing History:
2 out of 2 
1 out of 1 
1 out of 94 
Years Active: 2013-2023
Title: The Innovative Journey of Jacob Hendrik Beijnen
Introduction
Jacob Hendrik Beijnen is an accomplished inventor based in Amsterdam, Netherlands, with a remarkable track record of five patents. His innovative contributions primarily focus on the field of cancer treatment, showcasing a commitment to advancing medical therapies and improving patient outcomes.
Latest Patents
Among Beijnen's latest patents is a groundbreaking method for cancer treatment using docetaxel. This invention revolves around a novel approach to chemotherapy, specifically targeting tumors with taxanes, particularly docetaxel. The method focuses on orally administering an effective dose of docetaxel while controlling the peak plasma levels to minimize side effects. This innovative technique aims to maintain an effective plasma level sufficient to eradicate tumor cells without inducing adverse reactions.
Another significant patent by Beijnen includes pharmaceutical formulations of ecteinascidin compounds. This patent provides details on the formulations, methods for preparation, and articles of manufacture related to ecteinascidin, as well as kits designed for treating proliferative diseases utilizing these formulations.
Career Highlights
Throughout his career, Beijnen has made significant strides in pharmaceutical research and development. He has collaborated with reputable companies such as Pharma Mar, S.A. and Sociedad Unipersonal, further establishing his influence in the field of oncology and drug development.
Collaborations
In his career, Jacob Hendrik Beijnen has worked alongside esteemed colleagues like Bastiaan Nuijen and Pilar Calvo Salve. Their collective efforts have contributed to advancements in cancer treatment modalities and the development of innovative therapeutic agents.
Conclusion
Jacob Hendrik Beijnen stands out as a pioneering inventor in the realm of cancer therapies. His inventions reflect a deep understanding of pharmaceutical science and a dedication to improving health outcomes for patients battling cancer. With ongoing research and collaboration, Beijnen continues to inspire innovation in the medical field, paving the way for future breakthroughs in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile